FCCPC has just released an investigation of the Failed Elective Cosmetic Surgical Procedures by an accused Dr. Anu of Med Contour and his associates, employees. Read the investigation below.
FCCPC RELEASE INVESTIGATION OF FAILED ELECTIVE COSMETIC SURGICAL PROCEDURES BY DR. ANU AND ASSOCIATES/EMPLOYEES/OPERATIVES OF MED CONTOUR
Pursuant to Sections 17(s),(t),(x),(y); 18; 32; 123, 123-125; 127-130 Federal Competition & Consumer Protection Act 2018
Tuesday, April 14, 2020: On April 11, 2020; the Federal Competition and Consumer Protection Commission (FCCPC) became aware of complaints and dissatisfaction with respect to certain elective/cosmetic surgical procedures carried out by Med Contour services. Essentially, the allegations are that Med Contour engages in conduct that is considered otherwise unprofessional, misleading and potentially injurious, including resulting in possible fatalities.
The Commission’s initial review indicates that there is sufficient probable cause to inquire into the consumer protection aspects of the representations and services of Med Contour, and its operatives. As such, the Commission has opened an active investigation into the practices and processes of Med Contour, its promoter, associates and employees.
This is not a professional/licensing or disciplinary inquiry. However, the issues of authorization of the business and or its promoters, associates or employees to conduct the subject surgical procedures; representations made to customers about their skills, generally expected outcomes for similar procedures, and assurances of specific outcomes in relevant cases; responsiveness during follow-up or post-procedure complaints; and transparency to consumers and applicable regulatory authorities, are implicated under the Federal Competition and Consumer Protection Act (FCCPA).
Sections 17(s),(t),(x),(y) and 130 prohibit obnoxious practices, require services to be safe and for the Commission to act to reduce risk of injury to consumers, as well as ensure services comply with applicable standards of care. Sections 123, 124 and 125 prohibit making misleading statements, issuing guarantees or statements about the efficacy, skills or probable outcomes with respect to services that are untested or scientifically unproven, and Sections 127, 128 and 129 prohibit unfair or unreasonable contract terms, exclusion, or waiver of legitimate liability for prevailing standards of care.
In furtherance of this investigation, the Commission is keen to gather additional information from consumers with previous experiences with Med Contour or its operatives, whether the experiences were satisfactory or otherwise, and from persons who have any such relevant information, including about the experiences of others.
The commiasion therefore request credible information in this regard in the form of a consice narrative of facts including the identity of the MED Contour operatives the interactions occured with. The information should be sent to email@example.com
Chief Executive Officer